J u m p t o c o n t e n t
M a i n m e n u
M a i n m e n u
N a v i g a t i o n
● M a i n p a g e ● C o n t e n t s ● C u r r e n t e v e n t s ● R a n d o m a r t i c l e ● A b o u t W i k i p e d i a ● C o n t a c t u s ● D o n a t e
C o n t r i b u t e
● H e l p ● L e a r n t o e d i t ● C o m m u n i t y p o r t a l ● R e c e n t c h a n g e s ● U p l o a d f i l e
S e a r c h
Search
A p p e a r a n c e
● C r e a t e a c c o u n t ● L o g i n
P e r s o n a l t o o l s
● C r e a t e a c c o u n t ● L o g i n
P a g e s f o r l o g g e d o u t e d i t o r s l e a r n m o r e ● C o n t r i b u t i o n s ● T a l k
( T o p )
1 E a r l y l i f e
2 C a r e e r
3 R e c o g n i t i o n
4 P e r s o n a l l i f e
5 R e f e r e n c e s
T o g g l e t h e t a b l e o f c o n t e n t s
P a u l H u d s o n ( b u s i n e s s m a n )
2 l a n g u a g e s
● F r a n ç a i s ● 中 文
E d i t l i n k s
● A r t i c l e ● T a l k
E n g l i s h
● R e a d ● E d i t ● V i e w h i s t o r y
T o o l s
T o o l s
A c t i o n s
● R e a d ● E d i t ● V i e w h i s t o r y
G e n e r a l
● W h a t l i n k s h e r e ● R e l a t e d c h a n g e s ● U p l o a d f i l e ● S p e c i a l p a g e s ● P e r m a n e n t l i n k ● P a g e i n f o r m a t i o n ● C i t e t h i s p a g e ● G e t s h o r t e n e d U R L ● D o w n l o a d Q R c o d e ● W i k i d a t a i t e m
P r i n t / e x p o r t
● D o w n l o a d a s P D F ● P r i n t a b l e v e r s i o n
A p p e a r a n c e
F r o m W i k i p e d i a , t h e f r e e e n c y c l o p e d i a
Paul Hudson (born 14 October 1967)[2] Sanofi , the world's fifth largest pharmaceutical company by prescription drug sales.[3]
Early life [ edit ]
Hudson earned a degree in economics from Manchester Metropolitan University , and a diploma in marketing from the Chartered Institute of Marketing .[1]
Hudson has been CEO of Sanofi since September 2019.[4] [5] [6]
Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca , rising to president, AstraZeneca United States and Executive Vice President, North America.[6] [7] [8]
Recognition [ edit ]
Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.[1] [9]
Personal life [ edit ]
Hudson has three children with his wife Sandra and is an "ardent Manchester United football fan".[1]
References [ edit ]
^ Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine" – via www.theguardian.com.
^ "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved" . Fortune .
^ "Sanofi's CEO on a big acquisition, long-term strategy, and vaccines" . 17 August 2020.
^ a b "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership" . Russell Reynolds Associates . Archived from the original on 24 February 2021. Retrieved 26 January 2021 .
^ "AstraZeneca announces changes to Senior Executive Team" . Fiercepharma .
^ "Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis" . Novartis . Retrieved 24 April 2023 .
^ "Paul Hudson" . Manchester Metropolitan University . Retrieved 24 April 2023 .
t
e
Predecessors
CEOs
Main products
Cardiovascular
Thrombosis
Oncology
Diabetes
Central nervous system
Internal medicine
Chattem Inc.
R e t r i e v e d f r o m " https://en.wikipedia.org/w/index.php?title=Paul_Hudson_(businessman)&oldid=1229913715 " C a t e g o r i e s : ● L i v i n g p e o p l e ● B r i t i s h c h i e f e x e c u t i v e s ● A l u m n i o f M a n c h e s t e r M e t r o p o l i t a n U n i v e r s i t y ● S a n o f i p e o p l e ● N o v a r t i s p e o p l e ● A s t r a Z e n e c a p e o p l e ● G S K p l c p e o p l e ● 1 9 6 7 b i r t h s H i d d e n c a t e g o r i e s : ● U s e d m y d a t e s f r o m J a n u a r y 2 0 2 1 ● U s e B r i t i s h E n g l i s h f r o m J a n u a r y 2 0 2 1 ● A r t i c l e s w i t h h C a r d s ● T e m p l a t e : S u c c e s s i o n b o x : ' a f t e r ' p a r a m e t e r i n c l u d e s t h e w o r d ' i n c u m b e n t ' ● S - a f t : ' a f t e r ' p a r a m e t e r i n c l u d e s t h e w o r d ' i n c u m b e n t '
● T h i s p a g e w a s l a s t e d i t e d o n 1 9 J u n e 2 0 2 4 , a t 1 1 : 4 1 ( U T C ) . ● T e x t i s a v a i l a b l e u n d e r t h e C r e a t i v e C o m m o n s A t t r i b u t i o n - S h a r e A l i k e L i c e n s e 4 . 0 ;
a d d i t i o n a l t e r m s m a y a p p l y . B y u s i n g t h i s s i t e , y o u a g r e e t o t h e T e r m s o f U s e a n d P r i v a c y P o l i c y . W i k i p e d i a ® i s a r e g i s t e r e d t r a d e m a r k o f t h e W i k i m e d i a F o u n d a t i o n , I n c . , a n o n - p r o f i t o r g a n i z a t i o n . ● P r i v a c y p o l i c y ● A b o u t W i k i p e d i a ● D i s c l a i m e r s ● C o n t a c t W i k i p e d i a ● C o d e o f C o n d u c t ● D e v e l o p e r s ● S t a t i s t i c s ● C o o k i e s t a t e m e n t ● M o b i l e v i e w
